Literature DB >> 20690050

Recipient block TMA technique.

Martina Mirlacher1, Ronald Simon.   

Abstract

New high-throughput screening technologies have led to the identification of hundreds of genes with a potential role in cancer or other diseases. One way to prioritize the leads obtained in such studies is to analyze a large number of tissues for candidate gene expression. The TMA methodology is now an established and frequently used tool for high-throughput tissue analysis. The recipient block technology is the "classical" method of TMA making. In this method, minute cylindrical tissue punches typically measuring 0.6 mm in diameter are removed from donor tissue blocks and are transferred into empty "recipient" paraffin blocks. Up to 1,000 different tissues can be analyzed in one TMA block. The equipment is affordable and easy to use in places where basic skills in histology are available.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20690050     DOI: 10.1007/978-1-60761-806-5_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  31 in total

1.  Prognostic value of alpha-methyl CoA racemase (AMACR) expression in renal cell carcinoma.

Authors:  Christian Eichelberg; Sarah Minner; Hendrik Isbarn; Eike Burandt; Luigi Terracciano; Holger Moch; Alexandra Kell; Roman Heuer; Felix K Chun; Guido Sauter; Margit Fisch; Pierre Tennstedt
Journal:  World J Urol       Date:  2011-10-19       Impact factor: 4.226

2.  Aberrant expression of Sec61α in esophageal cancers.

Authors:  Kai Bachmann; Maximillian Bockhorn; Oliver Mann; Florian Gebauer; Marco Blessmann; Jakob Robert Izbicki; Katharina Grupp
Journal:  J Cancer Res Clin Oncol       Date:  2019-06-13       Impact factor: 4.553

3.  RAI3 is overexpressed in gastric adenocarcinoma but unrelated to prognosis.

Authors:  Nathaniel Melling; Kai Bachmann; Maximillian Bockhorn; Oliver Mann; Jakob Robert Izbicki; Katharina Grupp
Journal:  Int J Clin Exp Pathol       Date:  2019-02-01

4.  Alpha-methylacyl-CoA racemase (AMACR) expression in epithelial ovarian cancer.

Authors:  Aurelia Noske; Anne-Katrin Zimmermann; Rosmarie Caduff; Zsuzsanna Varga; Daniel Fink; Holger Moch; Glen Kristiansen
Journal:  Virchows Arch       Date:  2011-06-04       Impact factor: 4.064

5.  Loss of H2Bub1 Expression is Linked to Poor Prognosis in Nodal Negative Colorectal Cancers.

Authors:  Nathaniel Melling; Norbert Grimm; Ronald Simon; Philip Stahl; Carsten Bokemeyer; Luigi Terracciano; Guido Sauter; Jakob R Izbicki; Andreas H Marx
Journal:  Pathol Oncol Res       Date:  2015-09-07       Impact factor: 3.201

6.  High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers.

Authors:  Katharina Grupp; Stella Sanader; Hüseyin Sirma; Ronald Simon; Christina Koop; Kristina Prien; Claudia Hube-Magg; Georg Salomon; Markus Graefen; Hans Heinzer; Sarah Minner; Jakob R Izbicki; Guido Sauter; Thorsten Schlomm; Maria Christina Tsourlakis
Journal:  Mol Oncol       Date:  2013-07-19       Impact factor: 6.603

7.  Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer.

Authors:  Phillip Stahl; Carsten Seeschaaf; Patrick Lebok; Asad Kutup; Maximillian Bockhorn; Jakob R Izbicki; Carsten Bokemeyer; Ronald Simon; Guido Sauter; Andreas H Marx
Journal:  BMC Gastroenterol       Date:  2015-02-05       Impact factor: 3.067

8.  Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer.

Authors:  Martina Kluth; Ramin Ahrary; Claudia Hube-Magg; Malik Ahmed; Heinke Volta; Catina Schwemin; Stefan Steurer; Corinna Wittmer; Waldemar Wilczak; Eike Burandt; Till Krech; Meike Adam; Uwe Michl; Hans Heinzer; Georg Salomon; Markus Graefen; Christina Koop; Sarah Minner; Ronald Simon; Guido Sauter; Thorsten Schlomm
Journal:  Oncotarget       Date:  2015-09-29

9.  High mitochondria content is associated with prostate cancer disease progression.

Authors:  Katharina Grupp; Karolina Jedrzejewska; Maria Christina Tsourlakis; Christina Koop; Waldemar Wilczak; Meike Adam; Alexander Quaas; Guido Sauter; Ronald Simon; Jakob Robert Izbicki; Markus Graefen; Hartwig Huland; Thorsten Schlomm; Sarah Minner; Stefan Steurer
Journal:  Mol Cancer       Date:  2013-11-21       Impact factor: 27.401

10.  FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma.

Authors:  Katharina von Loga; Jule Kohlhaussen; Lia Burkhardt; Ronald Simon; Stefan Steurer; Susanne Burdak-Rothkamm; Frank Jacobsen; Guido Sauter; Till Krech
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.